Global state: Average endpoint global state score (clinically improved) (no data) · schizophrenia
1 finding from 1 review
Adverse effects: Clinically important general adverse effect (no data) · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride (Cis Z isomer) changes adverse effects: Clinically important general adverse effect compared with zuclopenthixol (Cis Z/Trans E isomer) (very low certainty).
1 finding from 1 review
Death: Suicide and natural causes (no data) · schizophrenia
1 finding from 1 review
Length of hospital stay · schizophrenia
1 finding from 1 review
Mental state: Average endpoint general mental state score (clinically improved) (no data) · schizophrenia
1 finding from 1 review
Leaving the study early · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride (Cis Z isomer) changes leaving the study early: Any reason compared with zuclopenthixol (Cis Z/Trans E isomer) (very low certainty).
1 finding from 1 review
General functioning: Average endpoint general functioning score (clinically improved) (no data) · schizophrenia
1 finding from 1 review
Stability of anterior open bite correction (1 year after treatment) · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
The review found no eligible studies for this question.
1 finding from 1 review
Failure to correct the anterior open bite (open bite not closed) · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
Frankel's function regulator-4 (FR-4) with lip-seal training led to lower failure to correct the anterior open bite (open bite not closed) compared with no treatment; GRADE not reported.
1 finding from 1 review
Duration of grade IV neutropenia (lower values signify better outcomes) · people with chemotherapy‐induced febrile neutropenia
Benefits and harms of CSF plus antibiotics showed no clear difference in duration of grade IV neutropenia (lower values signify better… compared with antibiotics alone (low certainty).
1 finding from 1 review
Anterior open bite correction · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
1 finding from 1 review
Orthodontic and orthopaedic treatment for anterior open bite in children 2014 · Cochrane All outcomesAbout 4 months (treatment interrupted early)
Could not be analysed statistically. After 4 months the open bite was observed to close in the magnet group, but in four out of these ten patients transverse problems (unilateral crossbite) were observed, which led to…
1 study
GRADE not reported
Failure to correct the anterior open bite (open bite not closed) · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
Removable appliance with palatal crib associated with high-pull… led to lower failure to correct the anterior open bite (open bite not closed) compared with no treatment; GRADE not reported.
1 finding from 1 review
Complication at donor site · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Prosthesis failure · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Rickert 2013 (split-mouth, N = 36): no prosthesis failures in either group.
1 study · 36 participants
GRADE not reported
Augmentation procedure failure · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Implant failure · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Complication at augmented site · Patients undergoing lateral-window maxillary sinus lift
Rotary instruments to open the lateral sinus window showed no clear difference in complications at augmented site compared with piezosurgery to open the lateral sinus window; GRADE not reported.
1 finding from 1 review
Serious adverse events maximum · newborns with late‐onset sepsis
It is very uncertain whether meropenem changes serious adverse events maximum compared with standard care (very low certainty).
1 finding from 1 review
Neurological developmental impairment maximum · newborns with late‐onset sepsis
It is very uncertain whether meropenem changes neurological developmental impairment maximum compared with standard care (very low certainty).
1 finding from 1 review
Necrotising enterocolitis maximum · newborns with late‐onset sepsis
It is very uncertain whether meropenem changes necrotising enterocolitis maximum compared with standard care (very low certainty).
1 finding from 1 review